Worldwide News

Clinical diagnostics company Novacyt has launched a polymerase chain reaction (PCR) monkeypox assay in response to the recent outbreak of the virus non-endemic countries.   The company’s monkeypox assay is for research-use only (RUO) and has been developed in two forms for the detection of the virus genome in both of its West African and Central African […]

This is the latest episode of the free DDW podcast, “The pursuit of better cancer treatments”. It covers two narrated article written for Volume 22, Issue 3 –Summer 2021 of DDW. They are called “The personal touch: the scientist making an impact in cancer research” and “Biotech’s pursuit of next-generation CAR-T”.  In the first article, […]

Featuring Specialty Spotlight: Immunotherapy, the magazine is available to download and read for free on the DDW App. Key features of the summer issue include: Why immunocompromised people are ‘forgotten’: Championing female leaders across drug discovery and development: Improving quality control for CAR T cell therapies, plus exclusive interviews and articles on project management for drug development, […]

Early breast cancer patients in England will be able to access a new form of treatment following the recommendation for Eli Lilly’s abemaciclib by the National Institute of Health and Care Excellence (NICE).  The approval means that abemaciclib will be able to be used in combination with endocrine therapy in patients with hormone receptor-positive, HER2-negative, […]

In this infographic by NanoTemper, follow the steps a monoclonal antibody takes on its journey when filing for both an investigational new drug (IND) and biologics license application (BLA). In the infographic, learn about: • The typical timeline and steps for the approval of a monoclonal antibody as a drug • The definitions and objectives of both […]

GSK and Sanofi have reported positive efficacy data from a co-developed vaccine targeting the Omicron variant of Covid-19.   The report makes GSK and Sanofi the first companies to have a vaccine candidate for the Omicron variant which has demonstrated efficacy.  Specifically, the companies’ B.1.351 vaccine candidate demonstrated 64.7% efficacy in symptomatic Covid-19 adults and 72% […]

The Veeva R&D and Quality Summit Europe gathered over 500 life sciences leaders in Zurich to explore new approaches for advancing digital trials and improving the clinical, quality, regulatory, and safety processes throughout.   The Summit, which took place at the start of June saw attendees learn about industry-leading strategies to streamline processes across the product […]

GSK is to invest £1 billion over the course of 10 years into research on infectious diseases that largely affect low-income countries.   In particular, the pharmaceutical company will aim to develop new vaccines and medicines that prevent and treat malaria, tuberculosis, HIV (through ViiV Healthcare), neglected tropical diseases (NTDs), and anti-microbial resistance (AMR) – all […]

News round-up by DDW’s Reece Armstrong for 20-24 June. Covid-19 vaccine development and research, gene therapies for dementia and a ‘game-changing’ treatment for HIV are some of the themes of this week’s news round-up. Moderna to set up mRNA vaccine centre in UK  Pharmaceutical company Moderna is to set-up a manufacturing and research development centre […]

Pharmaceutical company Moderna is to set-up a manufacturing and research development centre in the UK following an agreement with the government.   The new mRNA Innovation and Technology Centre will develop mRNA vaccines for respiratory diseases including Covid-19 vaccines that can protect against multiple variants. The aim for the centre is to help future-proof the UK […]